Cullgen Competitors and Similar CompaniesClear all

Cullgen's competitors and similar companies include NextCure, Kite Pharma and Ayala Pharmaceuticals.
Cullgen
Cullgen
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
NextCure
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Kite Pharma
Kite Pharma
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
Ayala Pharmaceuticals
Ayala Pharmaceuticals
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
Founding Date
Founding Date
2018
Founding Date
2015
Founding Date
2009
Founding Date
2017
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Shanghai, CN
Tokyo, JP
Locations
Beltsville, US HQ
Locations
Santa Monica, US HQ
Hoofddorp, NL
London, GB
El Segundo, US
Emeryville, US
Frederick, US
Oceanside, US
see more
Locations
Wilmington, US HQ
Rehovot, IL
Wilmington, US
Employees
Employees
4
Employees
N/A
Employees
3,9671% decrease
Employees
29
Valuation ($)
Valuation ($)
N/A
Valuation ($)
39.2 m
Valuation ($)
N/A
Valuation ($)
7.4 m

Financial

Net income
Net income
N/A
Net income
($55.8m) (FY, 2025)
Net income
N/A
Net income
($38m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 31m
Total funding raised
$ 160m
Total funding raised
$ 85.3m
Total funding raised
$ 47m
For sources of this data, please see the company profile

View Company Profiles

NextCure
HQ
Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

View company
Kite Pharma
HQ
Santa Monica, US

Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.

View company
Ayala Pharmaceuticals
HQ
Wilmington, US
Employees
29

Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.

View company